OBJECTIVE: Cochlear implantation is a common treatment approach for children with auditory neuropathy/dyssynchrony (AN/AD) who do not benefit from hearing aids. The auditory brainstem response (ABR) is a measure of neural synchrony along the auditory pathway up through the brainstem. By definition, acoustically evoked ABR is absent in AN/AD, however, ABR can be elicited by electrical stimulation through the cochlear implant (electrically evoked ABR [EABR]). Reports of EABR with AN/AD to date have been primarily descriptive in nature. The objective of this study was to quantify EABR wave V measures in implanted children with and without AN/AD. STUDY DESIGN: Retrospective analysis of EABR waveforms from March 2000 through February 2005. SETTING: Comprehensive Cochlear Implant Program/Tertiary Referral Center. PATIENTS: Pediatric cochlear implant users of two etiologic groups: congenital AN/AD (n = 5) and other congenital profound sensorineural hearing loss (n = 27). INTERVENTION: Diagnostic. MAIN OUTCOME MEASURES: Intraoperative EABR wave V threshold, suprathreshold amplitude, and latency measures were compared between groups. RESULTS: The EABR threshold and suprathreshold amplitude measures across the population were variable regardless of etiology. With some exceptions, a trend was observed for the AN/AD group that included average or below-average thresholds and below-average suprathreshold response amplitudes. CONCLUSION: Cochlear implantation can provide synchronous neural responses to auditory stimulation in AN/AD, as previously known. The quantification of EABR measures in this study indicates that subjects with AN/AD have sufficient neural sensitivity to electrical stimulation, however, they may experience less robust neural responses at suprathreshold levels. Given the heterogeneity of potential causes of AN/AD, however, caution needs to be applied when grouping this population for analyses.
OBJECTIVE: Cochlear implantation is a common treatment approach for children with auditory neuropathy/dyssynchrony (AN/AD) who do not benefit from hearing aids. The auditory brainstem response (ABR) is a measure of neural synchrony along the auditory pathway up through the brainstem. By definition, acoustically evoked ABR is absent in AN/AD, however, ABR can be elicited by electrical stimulation through the cochlear implant (electrically evoked ABR [EABR]). Reports of EABR with AN/AD to date have been primarily descriptive in nature. The objective of this study was to quantify EABR wave V measures in implanted children with and without AN/AD. STUDY DESIGN: Retrospective analysis of EABR waveforms from March 2000 through February 2005. SETTING: Comprehensive Cochlear Implant Program/Tertiary Referral Center. PATIENTS: Pediatric cochlear implant users of two etiologic groups: congenital AN/AD (n = 5) and other congenital profound sensorineural hearing loss (n = 27). INTERVENTION: Diagnostic. MAIN OUTCOME MEASURES: Intraoperative EABR wave V threshold, suprathreshold amplitude, and latency measures were compared between groups. RESULTS: The EABR threshold and suprathreshold amplitude measures across the population were variable regardless of etiology. With some exceptions, a trend was observed for the AN/AD group that included average or below-average thresholds and below-average suprathreshold response amplitudes. CONCLUSION: Cochlear implantation can provide synchronous neural responses to auditory stimulation in AN/AD, as previously known. The quantification of EABR measures in this study indicates that subjects with AN/AD have sufficient neural sensitivity to electrical stimulation, however, they may experience less robust neural responses at suprathreshold levels. Given the heterogeneity of potential causes of AN/AD, however, caution needs to be applied when grouping this population for analyses.
Authors: Christina L Runge; Jamie Jensen; David R Friedland; Ruth Y Litovsky; Sergey Tarima Journal: J Am Acad Audiol Date: 2011-10 Impact factor: 1.664
Authors: Shuman He; John H Grose; Holly F B Teagle; Jennifer Woodard; Lisa R Park; Debora R Hatch; Craig A Buchman Journal: Ear Hear Date: 2013 Nov-Dec Impact factor: 3.570
Authors: Christina L Runge; Christy B Erbe; Mark T McNally; Courtney Van Dusen; David R Friedland; Anne E Kwitek; Joseph E Kerschner Journal: Audiol Neurootol Date: 2013-10-15 Impact factor: 1.854